Cramer’s Drug Research/CRO Stocks (CVD, PRXL)
On tonight’s MAD MONEY on CNBC, Jim Cramer came out with a positive tease early on in the contract research organization sector (CRO’s) as it pertains to drugs, biotech, and medical research. He thinks…
Archive
Year: 2008
All Year: 2008 Articles
Newest first · Page 411Cramer Calls On Oversold & Overlooked Tech Stocks (IBM, EMC, VMW, INTC, MSFT, HPQ, GLW, AAPL, RIMM, GOOG)
On tonight’s MAD MONEY on CNBC, Jim Cramer said that after IBM (NYSE: IBM) raised its numbers that was just the excuse to rally tech as it was and oversold. he noted, "Nothing was…
More Rumors Of Big Cuts At Citigroup (C)
According to The Wall Street Journal Citigroup (C) is "expected to announce a sizable dividend cut, cash infusion of at least $10 billion and write-down of as much as $20 billion in mortgage-related investments."…
Verizon (VZ) FiOS Great For Subscribers, Stinks For Investors
From Silicon Alley Insider Verizon has apparently done a good job designing and building its "FiOS" bundle of digital TV, super-fast Internet access, and phone service: It took the top spot in Consumer Reports’…
As Fidelity Re-Opens Magellan Fund, Investors Review Top Holdings (FMAGX, NOK, GLW, GOOG, SLB, CNQ, SPLS, T, AGN, MON)
It’s official. Fidelity’s Magellan Fund (FMAGX) is being re-opened for new investors. This fund at one point in 1997 became so large that the fund closed itself to new funds and outside investment commitments. …
Genentech Earnings Win, But Drugs Miss (DNA)
Genentech (NYSE: DNA) just announced its earnings were $0.69 EPS on $2.96 billion for the last quarter, and First Call had estimates pegged at $0.67 EPS on revenues of $2.97 Billion. The company has…
The 52-Week Low Club (HAR)(TIF)(OPWV)
Harman (HAR) Cuts forecasts and that cuts stock price. Falls to $42.88 from 52-week high of $125.13. Tiffany (TIF) Even the rich are being pinched. Down to $32.84 from 52-week high of $57.34. Coach…
Biotech Finance Daily (DNDN)(MRK)(DNA)(BRCX)
Shares of ImaRx Therapeutics (IMRX) are off 15% to $1.18. The company’s news about it Transcranial Ultrasound in Clinical SONolysis clinical trial in patients with acute ischemic stroke disappointed the market a little over…
Can Genentech Buck Its Long-Term Slide? (DNA, BIIB, NVS, OSIP, AMGN, BBH)
Genentech (NYSE: DNA) is set to report earnings after the close today. First Call has estimates pegged at $0.67 EPS on revenues of $2.97 Billion. This will also mark the end of the fiscal…
Citigroup: Forget Earnings, Look At Its Plan (C)
Citigroup (NYSE: C) is set to report earnings tomorrow morning. While this will be the first of the big money center banks and financial conglomerates to officially report earnings, the actual earnings may be…
EU Won’t Leave Microsoft (MSFT) Alone
Now that Microsoft (MSFT) and the EU seems to have come close to settling differences on the Window Media Player, the government body is back after Redmond again. According to Reuters "a European Union…
ETF Launch: Coal, Via Van Eck (KOL, CNX, BTU, ACI, JOYG, BUCY, TA)
This morning we have another ETF being launched that is quite sector specific. Van Eck Associated has listed the Market Vectors Coal ETF (NYSE: KOL). While we have noted some ETF’s being too focused…
Terex Wins Twice (TEX, ASVI)
Terex Corp. (NYSE: TEX) is seeing a double plus good reaction this morning. This weekend’s version of Barron’s noted a solid long-term opportunity in shares of the company AND it is making an acquisition.…
The Apple (AAPL) MacBook Air?
Apple (AAPL) may be releasing an ultra-thin notebook at MacWorld. According to Macrumors it will have the unlikely name "MacBook Air." Maybe Michael Jordan will be there. Douglas A. McIntyre
IBM To Tech’s Rescue (IBM, CSCO, HPQ, MSFT, DELL, INTC)
IBM (IBM) has come out raised guidance this morning on strong international orders. Big Blue put earnings at $2.80 EPS, and the First Call estimate was $2.60 EPS. and revenues came in at $28.9…